CV Sciences ( (CVSI) ) has issued an update. CV Sciences, Inc., a leader in consumer wellness products, reported a third-quarter 2024 revenue ...

Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...

Third Point took new stakes in Tesla (NASDAQ:TSLA), with 400K shares, CVS Health (NYSE:CVS), with 1.58M shares, and ...

CV Sciences Q3 2024 financial results: stable $3.9M revenue, improved 46% gross margin, new products, and nearing cash flow break-even.